Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Journey Medical (DERM) over the last 5 years, with Q3 2025 value amounting to 0.13%.

  • Journey Medical's Return on Capital Employed rose 4500.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 4500.0%. This contributed to the annual value of 0.32% for FY2024, which is 2700.0% down from last year.
  • As of Q3 2025, Journey Medical's Return on Capital Employed stood at 0.13%, which was up 4500.0% from 0.16% recorded in Q2 2025.
  • Journey Medical's Return on Capital Employed's 5-year high stood at 0.07% during Q2 2024, with a 5-year trough of 2.51% in Q2 2023.
  • Its 5-year average for Return on Capital Employed is 0.59%, with a median of 0.52% in 2022.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first crashed by -19900bps in 2023, then soared by 25800bps in 2024.
  • Over the past 5 years, Journey Medical's Return on Capital Employed (Quarter) stood at 0.84% in 2021, then grew by 18bps to 0.69% in 2022, then surged by 90bps to 0.07% in 2023, then plummeted by -427bps to 0.37% in 2024, then soared by 66bps to 0.13% in 2025.
  • Its last three reported values are 0.13% in Q3 2025, 0.16% for Q2 2025, and 0.16% during Q1 2025.